Sarah Pickett:  Research

phone: c/o/ +353 1 402 2841
email:

sarah.sabourpickett@gmail.com

Profile
Publications

Current Projects

Prognostic indicators and outcome measures for patients with neovascular age-related macular degeneration undergoing treatment with intravitreal ranibizumab

In this study, we are investigating visual performance, and its response to treatment, in patients with neovascular age-related macular degneration (nv-AMD) by performing an array of psychophysical tests in patients undergoing a course of intravitreal ranibizumab injections for their condition. The purpose of this study is to explore whether alternative psychophysical testing is more appropriate than, or complimentary to, corrected distance visual acuity (CDVA) (the standard and most commonly utilised method for assessing vision) in reflecting the patient’s visual experience, and if so, whether such alternative parameters are more sensitive to changes in retinal thickness than is CDVA.

 

Functional, morphological and biochemical responses to supplementation with three different macular carotenoid formulations, in patients with early AMD

This study is designed to compare three different carotenoid-based products, in a single-blind, randomised fashion, with respect to changes in MP optical density and serum concentrations of MZ, L and Z in patients with early AMD. This study will also investigate whether MP augmentation enhances visual function and/or reduces AMD severity in patients with early AMD, and in addition, whether such changes relate to product formulation.

Back to Top

     Find us on Facebook      Follow us on Twitter      Follow us on LinkedIn

Member of the European University Association